Articles
Media perspectives: Ed Silverman

Media perspectives: Ed Silverman

Kicking off the start of a new series where we speak with key media figures in pharma and healthcare, pharmaphorum caught up with Ed Silverman, the Editor of Pharmalot. There’s never a dull moment in pharma, with every day bringing new breaking stories covering everything from updates on development and…

Articles
The ‘supply chain’ patient is sick: is there a cure for the Pharma Supply Chain? (part 1)

The ‘supply chain’ patient is sick: is there a cure for the ...

In the first of two parts, Hedley Rees looks at the problems with the pharmaceutical supply chain and questions whether they can be resolved. The Pharmaceutical supply chain has never been in such turmoil and under such attack from governments and regulators globally. The evidence is...

Articles
HIV/AIDS statistics in South Africa: and the possible implications for the tx and dx industries (part 2)

HIV/AIDS statistics in South Africa: and the possible implic...

Chris Jennings continues his article highlighting ways in which he believes HIV / AIDS incidence have been overestimated. As described in Part I of this article, few people realize that the familiar HIV/AIDS global statistics are actually estimates. For example...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more